Abstract:Intratumoral hypoxia significantly constrains the susceptibility of solid tumors to oxygen-dependent photodynamic therapy (PDT), and effort to reverse such hypoxia has achieved limited success to date. Herein, we developed a novel engineered bacterial system capable of targeting hypoxic tumor tissues and efficiently mediating the photodynamic treatment of these tumors. For this system, we genetically engineered Escherichia coli to express catalase, after which we explored an electrostatic adsorption approach to link black phosphorus quantum dots (BPQDs) to the surface of these bacteria, thereby generating an engineered E. coli/BPQDs (EB) system. Following intravenous injection, EB was able to target hypoxic tumor tissues. Subsequent 660 nm laser irradiation drove EB to generate reactive oxygen species (ROS) and destroy the membranes of these bacteria, leading to the release of catalase that subsequently degrades hydrogen peroxide to yield oxygen. Increased oxygen levels alleviate intratumoral hypoxia, thereby enhancing BPQD-mediated photodynamic therapy. This system was able to efficiently kill tumor cells in vivo, exhibiting good therapeutic efficacy. In summary, this study is the first to report the utilization of engineered bacteria to facilitate PDT, and our results highlight new avenues for BPQD-mediated cancer treatment.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c20254?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c20254</a>.Materials, methods, oxygen generation in 3% H2O2 solution after different bacteria lysis treatments as measured by a dissolved oxygen meter (Figure S1); AFM image of BPQDs (Figure S2); absorbance spectra of EB before and after rotation (Figure S3); height profiles of the BPQDs (Figure S4); CLSM photo of pure E. coli modified with DSPE-PEG-Cy5 (Figure S5); DCFH-DA fluorescence intensity (Figure S6); viability of E. coli survival rate (Figure S7); blood biochemistry data of kidney function markers: CRE and BUN (Figures S8 and S9); blood biochemistry data of liver function markers: ALT, ALP, and AST (Figure S10); histopathologic examination of tissues (Figure S11); and DCFH-DA fluorescence intensity (Figure S12) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c20254/suppl_file/am0c20254_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Bacteria‐Assisted Selective Photothermal Therapy for Precise Tumor Inhibition

Genetically modified bacteria for targeted phototherapy of tumor

Dual-targeted and MRI-guided Photothermal Therapyviairon-Based Nanoparticles-Incorporated Neutrophils

Recent advances in selective photothermal therapy of tumor

Photothermal Lysis of Engineered Bacteria to Modulate Amino Acid Metabolism against Tumors

A Photothermally-Induced HClO-releasing Nanoplatform for Imaging-Guided Tumor Ablation and Bacterial Prevention.

Redox-activatable photothermal therapy and enzyme-mediated tumor starvation for synergistic cancer therapy

An Amphiphilic Tetraphenylethylene-Based Photosensitizer for Cancer Cell Ablation and Bacteria Killing

Near‐Infrared II Light‐Triggered Robust Carbon Radical Generation for Combined Photothermal and Thermodynamic Therapy of Hypoxic Tumors

Aggregation-Induced Emission Photosensitizer/Bacteria Biohybrids Enhance Cerenkov Radiation-Induced Photodynamic Therapy by Activating Anti-Tumor Immunity for Synergistic Tumor Treatment

Self‐Mineralized Photothermal Bacteria Hybridizing with Mitochondria‐Targeted Metal–Organic Frameworks for Augmenting Photothermal Tumor Therapy

Novel Engineered Bacterium/Black Phosphorus Quantum Dot Hybrid System for Hypoxic Tumor Targeting and Efficient Photodynamic Therapy

Bright Bacterium for Hypoxia‐Tolerant Photodynamic Therapy Against Orthotopic Colon Tumors by an Interventional Method

A Strategy for Enhanced Tumor Targeting of Photodynamic Therapy Based on Escherichia Coli-Driven Drug Delivery System

TME-targeting theranostic agent uses NIR tracking for tumor diagnosis and surgical resection and acts as chemotherapeutic showing enhanced efficiency and minimal toxicity

Supramolecular Porphyrin Photosensitizers Based on Host−Guest Recognition for In Situ Bacteria‐Responsive Near‐Infrared Photothermal Therapy

Specific Photothermal Therapy to the Tumors with High EphB4 Receptor Expression

Bacteria-based cascade in situ near-infrared nano-optogenetically induced photothermal tumor therapy

Bacteria-mediated Tumor Immunotherapy Via Photothermally-Programmed PD1 Expression

Enhanced Photothermal Therapy through the In Situ Activation of a Temperature and Redox Dual‐Sensitive Nanoreservoir of Triptolide

Effective Eradication of Tumors by Enhancing Photoacoustic‐Imaging‐Guided Combined Photothermal Therapy and Ultrasonic Therapy